2 
MINUTES OF MEETING - June 5-6 
The following non-voting members and liaison representatives were present : 
Dr. Charlotte Bell, U. S. Department of Justice; Dr. Walter R. Dowdle, Center 
for Disease Control; Dr. George Duda, U. S. Department of Energy; Dr. George 
Gordon, U. S. Department of Commerce; Dr. Richard Hedrich, National Endowment 
for the Humanities; Dr. Timothy J. Henry, Food and Drug Administration; 
Dr. Tetsuo lino, University of Ibkyo; Dr. Herman Lewis, National Science Founda- 
tion; Dr. David Logan, U. S. Department of Labor; Mr. Melvin Myers, National 
Institute for Occupational Safety and Health; Dr. Jane Schultz, U. S. Veterans 
Administration; Dr. Sue Tblin, U. S. Department of Agriculture; and Dr. William J. 
Walsh, III, U. S. Department of State. 
Other National Institutes of Health staff present were ; 
Dr. Marilyn Bach, NIAID; Dr. Stanley Barban, NIAID; Dr. W. Emmett Barkley, 
ORS; Mrs. Betty Butler, NIAID; Dr. Robert J. Byrne, NIAID; Dr. Irving Delappe, 
NIAID; Dr. Donald S. Fredrickson, Director, NIH; Dr. Steve Havas, NHLBI; 
Dr. John Irwin, ORS; Dr. Richard Krause, NIAID; Dr. Elizabeth Milewski, NIAID; 
Dr. Stanley Nagle, NIAID; Dr. John Nutter, NIAID; Dr. Carl Rhodes, NICMS; 
Mr. Marc Stem, OC-OD; Dr. Bernard Talbot, OD; Dr. Rudolf Wanner, ORS; Ms. N. 
Wender, OC-OD; Dr. Karl Western, NIAID; and Dr. Burke Zimmerman, OD. 
Others in attendance for all or part of the meeting were ; 
Dr. John Adams, Pharmaceutical Manufacturers Association; Dr. Lucile Adamson, 
Occupational Safety and Health Administration; Dr. E. A. Agostini, Pfizer, Inc.; 
Dr. Howard Bachrach, U. S. Department of Agriculture; Dr. D. E. Baldwin, 
Schering Corporation; Dr. Barry Beyer, Schering Corporation; Dr. Peter Bostock, 
New Brunswick Scientific Company, Inc.; Dr. Richard Brock, Australian Embassy; 
Dr. William Can, Jack Raymond & Company; Mr. Bob Byrnes, Genentech, Inc.; 
Dr. Jerry Call is, U. S. Department of Agriculture; Dr. C. T. Chen, Occupational 
Safety and Health Administration; Mr. Jeffrey Christy, Blue Sheet; Dr. R. John 
Collins, University of California, Los Angeles; Dr. Aileen Compton, Smith-Kline; 
Dr. T. H. Fraser, Upjohn Company; Dr. Jeffrey Freedman, Office of General Council, 
DHHS; Dr. Leonard C. Gosule, Food and Drug Administration; Dr. Patricia Guerry, 
Genex Corporation; Dr. Lowell Harmison, Office of Assistant Secretary for Health; 
Dr. Zsolt Harsanyi, Office of Technology Assessment; Dr. Paul Hung, Abbott 
Research Laboratories; Dr. James Hunt, Chemapec ; Dr. Evelyn Hurlburt, Johns 
Hopkins School of Hygiene; Dr. Dorothy Jessup, U. S. Department of Agriculture; 
Dr. Irving Johnson, Eli Lilly & Company; Dr. Attila I. Kadar, Pood and Drug 
Administration; Mr. Alan Kaplan, Attorney, Washington, D. C.; Dr. Geoffrey Kamey, 
Office of Technology Assessment; Dr. Paul Kaufman, Pharmaceutical Manufacturers 
Association; Dr. Paul Leibowitz, Schering Corporation; Ms. Carter Leonard, Blue 
Sheet; Dr. M. A. Levine, Environmental Protection Agency; Dr. Dan Liberman, 
Massachusetts Institute of Technology; Dr. James McCullough, Library of Congress; 
Dr. T. McKillop, ICI Pharmaceuticals; Dr. J. Metcalfe, Environmental Protection 
Agency; Dr. Henry I. Miller, Food and Drug Administration; Dr. DeLill Nasser, 
[102J 
